SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-014565
Filing Date
2021-03-22
Accepted
2021-03-22 16:01:37
Documents
12
Period of Report
2021-03-17
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K onct-8k_20210317.htm   iXBRL 8-K 34164
  Complete submission text file 0001564590-21-014565.txt   163248

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA onct-20210317.xsd EX-101.SCH 5780
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE onct-20210317_lab.xml EX-101.LAB 19471
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onct-20210317_pre.xml EX-101.PRE 11635
5 EXTRACTED XBRL INSTANCE DOCUMENT onct-8k_20210317_htm.xml XML 3570
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 21761313
SIC: 2834 Pharmaceutical Preparations